Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Ph. Eur. 01/2008:20223 "Atomic Absorption Spectrometry" Ph. Eur. 04/2013:20420 "Determination of Metal Catalyst or Metal Reagent Residues" USP-NF <852> "Atomic Absorption Spectroscopy"

Therapeutic Modalities:

Biologics

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP and GMP

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Ph. Eur. 2.2.5., USP<841> Method I and II

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP (ISO 9001:2015)

Pharmacopoeia:

Harmonized USP <616> Method I, and EP 2.9.34 and JP

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP

Therapeutic Modalities:

Biologics, Cell & Gene Therapies, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

USP <941>

Therapeutic Modalities:

Small Molecules

Development Phases:

Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Harmonized EP 2.9.1 and USP <701> and JP

Therapeutic Modalities:

Small Molecules

Development Phases:

Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Harmonized EP 2.9.3, USP <711>

Therapeutic Modalities:

Small Molecules

Development Phases:

Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

non-GMP (ISO 9001:2015)

Pharmacopoeia:

Harmonized EP 2.9.3, USP <711>, JP

Therapeutic Modalities:

Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical

Quality Standard:

non-GMP (ISO 9001:2015)

Pharmacopoeia:

USP <1087>

Therapeutic Modalities:

Biologics

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research

Quality Standard:

non-GMP (ISO 9001:2015) (Spectralservice) and non-GMP (ISO 9001:2015) (Uni Basel)

Therapeutic Modalities:

Biologics, Cell & Gene Therapies

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Therapeutic Modalities:

Small Molecules

Development Phases:

Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

EP 2.2.17, Method A available

Therapeutic Modalities:

Biologics, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP